These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8470424)

  • 21. Clinico-immunologic and allergologic studies with the inactivated influenza virus vaccine purified and concentrated by gradient centrifugation.
    Subbotina TI; Tenkova TV; Sidorova LV; Shpilyuk GF; Drinevsky VP; Voitsekhovskaya EM; Konstantinov VK; Sominina AA
    Acta Virol; 1988 Nov; 32(6):494-502. PubMed ID: 2906221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines.
    Mumford JA; Jessett D; Dunleavy U; Wood J; Hannant D; Sundquist B; Cook RF
    Vaccine; 1994 Jul; 12(9):857-63. PubMed ID: 7975864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual.
    Katz JM; Webster RG
    Virology; 1988 Aug; 165(2):446-56. PubMed ID: 3407150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus.
    Donnelly JJ; Friedman A; Martinez D; Montgomery DL; Shiver JW; Motzel SL; Ulmer JB; Liu MA
    Nat Med; 1995 Jun; 1(6):583-7. PubMed ID: 7585127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.
    Kirchenbaum GA; Carter DM; Ross TM
    J Virol; 2016 Jan; 90(2):1116-28. PubMed ID: 26559834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells.
    Katz JM; Webster RG
    J Gen Virol; 1992 May; 73 ( Pt 5)():1159-65. PubMed ID: 1588320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitope changes on the haemagglutinin molecule of recently isolated H1N1 influenza viruses.
    Yamada A; Nobusawa E; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S; Kim DW; Nakajima K; Nakajima S
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():97-102. PubMed ID: 1703564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies.
    Gerhard W; Yewdell J; Frankel ME; Webster R
    Nature; 1981 Apr; 290(5808):713-7. PubMed ID: 6163993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
    Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
    Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
    Yeolekar LR; Ganguly M; Tyagi P; Ingle NB; Stittelaar KJ; Waal L; Scorza FB; Mahmood K; Dhere RM
    Vaccine; 2018 Nov; 36(46):6944-6952. PubMed ID: 30322745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 33. Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers.
    Yamane N; Nakamura Y; Yuki M; Odagiri T; Ishida N
    J Hyg (Lond); 1984 Apr; 92(2):231-42. PubMed ID: 6707472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines.
    Ennis FA; Yi-Hua Q; Schild GC
    J Gen Virol; 1982 Feb; 58(Pt 2):273-81. PubMed ID: 7038041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge.
    Fries LF; Dillon SB; Hildreth JE; Karron RA; Funkhouser AW; Friedman CJ; Jones CS; Culleton VG; Clements ML
    J Infect Dis; 1993 Mar; 167(3):593-601. PubMed ID: 8440931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
    Keitel WA; Atmar RL; Nino D; Cate TR; Couch RB
    J Infect Dis; 2008 Oct; 198(7):1016-8. PubMed ID: 18729777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines.
    Nakowitsch S; Waltenberger AM; Wressnigg N; Ferstl N; Triendl A; Kiefmann B; Montomoli E; Lapini G; Sergeeva M; Muster T; Romanova JR
    Biotechnol J; 2014 Mar; 9(3):405-14. PubMed ID: 24323790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses.
    Rocha EP; Xu X; Hall HE; Allen JR; Regnery HL; Cox NJ
    J Gen Virol; 1993 Nov; 74 ( Pt 11)():2513-8. PubMed ID: 8245870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.